Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Diabetologia. 2020 Oct 1;64(1):159–167. doi: 10.1007/s00125-020-05281-7

Table 2.

Proportion of new adipocytes in the scABD and scFEM depots of Apple & Pear study participants

PLB
Week 0
PLB
Week 16
p value
Δ Week 0 vs
16
PIO
Week 0
PIO
Week 16
p value
Δ Week 0 vs
16
Δ PLB vs PIO p value
Δ PLB vs PIO
scABD (%) 7.1 ± 0.8 6.8 ± 1.1 0.84 7.6 ± 0.8 9.3 ± 1.1 0.23 2.0 ± 2.1 0.32
scFEM (%) 9.9 ± 0.9 8.7 ± 0.8 0.30 8.5 ± 0.9 10.6 ± 0.9 0.07 3.3 ± 1.6 0.04

Values are presented as mean ± SEM

PIO, pioglitazone group; PLB, placebo group